For citations:
Romanenko V.V., Namazova-Baranova L.S., Kotova A.A., Efendieva K.E., Ruleva A.A., Khait E.A., Perminova O.A., Pak T.E., Lazareva S.G., Aleshina L.V., Suprun D.A., Galustyan A.N., Rychkova O.A., Romanova T.A., Aminova A.I., Dulova G.V. Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive). Pediatric pharmacology. 2024;21(3):213-225. (In Russ.) https://doi.org/10.15690/pf.v21i3.2743
Email this article 